Laidlaw Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,755
| Closed | -$320K | – | 173 |
|
|
2024
Q1 | $320K | Sell |
1,755
-8,281
| -83% | -$1.51M | 0.18% | 131 |
|
|
2023
Q4 | $1.56M | Buy |
10,036
+689
| +7% | +$107K | 0.57% | 44 |
|
|
2023
Q3 | $1.39M | Sell |
9,347
-5,386
| -37% | -$803K | 0.46% | 62 |
|
|
2023
Q2 | $1.98M | Sell |
14,733
-510
| -3% | -$68.7K | 0.39% | 64 |
|
|
2023
Q1 | $2.43M | Sell |
15,243
-142
| -0.9% | -$22.6K | 0.5% | 54 |
|
|
2022
Q4 | $2.49M | Sell |
15,385
-1,182
| -7% | -$191K | 0.53% | 48 |
|
|
2022
Q3 | $2.22M | Buy |
16,567
+879
| +6% | +$118K | 0.52% | 52 |
|
|
2022
Q2 | $2.4M | Sell |
15,688
-717
| -4% | -$110K | 0.49% | 59 |
|
|
2022
Q1 | $2.66M | Sell |
16,405
-700
| -4% | -$113K | 0.44% | 57 |
|
|
2021
Q4 | $2.32M | Buy |
17,105
+976
| +6% | +$132K | 0.37% | 74 |
|
|
2021
Q3 | $1.74M | Buy |
16,129
+1,766
| +12% | +$191K | 0.45% | 69 |
|
|
2021
Q2 | $1.62M | Sell |
14,363
-14
| -0.1% | -$1.58K | 0.42% | 69 |
|
|
2021
Q1 | $1.56M | Buy |
14,377
+633
| +5% | +$68.5K | 0.53% | 53 |
|
|
2020
Q4 | $1.47M | Buy |
13,744
+5,804
| +73% | +$622K | 0.31% | 93 |
|
|
2020
Q3 | $695K | Buy |
7,940
+269
| +4% | +$23.5K | 0.31% | 90 |
|
|
2020
Q2 | $753K | Buy |
7,671
+3,280
| +75% | +$322K | 0.39% | 74 |
|
|
2020
Q1 | $335K | Buy |
+4,391
| New | +$335K | 0.22% | 107 |
|